hematologic malignancies
Genetron Health, Fosun Ink Commercialization Deal for Seq-MRD Test in China
The pharma firm is lending its large sales force to help promote the test across hospitals and clinics treating patients with hematologic cancers.
PLOS Papers on Breast Cancer Methylation, COVID 'Omics, Canine Hematopoietic Cancer Risk
In PLOS this week: DNA methylation patterns in breast cancer, multi-omic analysis of samples from COVID-19 patients, and more.
Genetron Health Licenses ImmuQuad Technology for Blood Cancer Testing
Under the agreement, Genetron gains exclusive rights to develop and commercialize minimal residual disease assays using ImmuQuad's immunogenomics technology.
Germline Variants Contribute to Risk of Developing Aging-Related Clonal Hematopoiesis
Researchers identified one germline variant near TET2 that appears to be specific to individuals of African ancestry.
MSK Clonal Hematopoiesis Clinic Aims to Drive New Strategies for Cancer Risk Assessment, Prevention
Premium
The program is in its third year monitoring individuals with these mutations to try to detect disease early, understand their risk, and develop preventive treatments.